サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：異種移植の世界市場 (～2027年)：動物タイプ・異種製品・臓器・エンドユーザー・地域別の競合予測および成長機会
市場調査レポート
商品コード
1121073

異種移植の世界市場 (～2027年)：動物タイプ・異種製品・臓器・エンドユーザー・地域別の競合予測および成長機会

Global Xenotransplantation Market By Animal Type, By Xeno Products, By Organs, By End Users, By Region, Competition Forecast & Opportunities, 2027
出版日: | 発行: TechSci Research | ページ情報: 英文 114 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

異種移植の世界市場 (～2027年)：動物タイプ・異種製品・臓器・エンドユーザー・地域別の競合予測および成長機会
出版日: 2022年10月01日
発行: TechSci Research
ページ情報: 英文 114 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の異種移植の市場は、予測期間である2023年から2027年にかけて安定したCAGRを記録すると予測されています。

世界の異種移植市場の需要は、主に人体移植用の臓器の不足や、臓器移植技術の発展などの要因によってもたらされています。慢性疾患の有病率の上昇や、参入事業者によるR&D活動へのハイエンドな投資も市場需要に影響を与えると予想されています。

当レポートでは、世界の異種移植の市場を調査し、市場概要、市場規模の推移・予測、各種区分・地域/主要国別の内訳、法規制環境、市場への各種影響因子の分析、競合環境、市場シェア、主要企業のプロファイルなどをまとめています。

目次

第1章 製品概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 COVID-19：世界の異種移植市場に与える影響

第5章 VOC (顧客の声)

  • 異種移植の認知度
  • 異種移植への切り替えに寄与する要因
  • 好み：動物タイプ別
  • 異種移植の採用に対する障壁

第6章 臨床試験分析

第7章 特許分析

第8章 成功した異種移植のケーススタディ

第9章 世界の異種移植市場の見通し

  • 市場規模・予測
  • 市場シェア・予測
    • 動物タイプ別（豚・ウサギ・ヒヒ・その他）
    • 異種製品別（臓器・組織・細胞）
    • エンドユーザー別（病院・移植センター・その他）
    • 企業別
    • 地域別
  • 製品市場マップ

第10章 北米の異種移植市場の見通し

  • 市場規模・予測
  • 市場シェア・予測
    • 動物タイプ別（豚・ウサギ・ヒヒ・その他）
    • 異種製品別（臓器・組織・細胞）
    • エンドユーザー別（病院・移植センター・その他）
    • 国別
  • 政策・規制状況
  • 国別分析

第11章 欧州の異種移植市場の見通し

  • 市場規模・予測
  • 市場シェア・予測
    • 動物タイプ別（豚・ウサギ・ヒヒ・その他）
    • 異種製品別（臓器・組織・細胞）
    • エンドユーザー別（病院・移植センター・その他）
    • 国別
  • 政策・規制状況
  • 国別分析

第12章 アジア太平洋の異種移植市場の見通し

  • 市場規模・予測
  • 市場シェア・予測
    • 動物タイプ別（豚・ウサギ・ヒヒ・その他）
    • 異種製品別（臓器・組織・細胞）
    • エンドユーザー別（病院・移植センター・その他）
    • 国別
  • 政策・規制状況
  • 国別分析

第13章 南米の異種移植市場の見通し

  • 市場規模・予測
  • 市場シェア・予測
    • 動物タイプ別（豚・ウサギ・ヒヒ・その他）
    • 異種製品別（臓器・組織・細胞）
    • エンドユーザー別（病院・移植センター・その他）
    • 国別
  • 政策・規制状況
  • 国別分析

第14章 中東およびアフリカの異種移植市場の見通し

  • 市場規模・予測
  • 市場シェア・予測
    • 動物タイプ別（豚・ウサギ・ヒヒ・その他）
    • 異種製品別（臓器・組織・細胞）
    • エンドユーザー別（病院・移植センター・その他）
    • 国別
  • 政策・規制状況
  • 国別分析

第15章 市場力学

  • 促進要因
  • 課題

第16章 市場動向・市場展開

第17章 SWOT分析：世界の異種移植市場

第18章 競合情勢

  • United Therapeutics Corporation
  • Immerge BioTherapeutics, Inc
  • eGenesis, Inc.
  • Infigen, Inc.
  • NZeno Limited
  • recombinetics（Makana Therapeutics）
  • Miromatrix Medical Inc.
  • Optipharm Co. Ltd
  • Xeno Transplants Corporation
  • Smithfield Foods, Inc.

第19章 戦略的提言

図表

List of Figures

  • Figure 1: Global Xenotransplantation Market Size, By Value (USD Million), 2021-2031F
  • Figure 2: Global Xenotransplantation Market Share, By Animal Type, By Value, 2021-2031F
  • Figure 3: Global Xenotransplantation Market Share, By Xeno Product, By Value, 2021-2031F
  • Figure 4: Global Xenotransplantation Market Share, By Organs, By Value, 2021-2031F
  • Figure 4: Global Xenotransplantation Market Share, By End User, By Value, 2021-2031F
  • Figure 5: Global Xenotransplantation Market Share, By Region, By Value, 2021-2031F
  • Figure 6: Global Xenotransplantation Market Share, By Company, 2021
  • Figure 7: Global Xenotransplantation Market Map, By Product, Market Size (USD Million) & Growth Rate (%), 2021
  • Figure 8: Global Xenotransplantation Market Map, By Animal Type, Market Size (USD Million) & Growth Rate (%), 2021
  • Figure 9: Global Xenotransplantation Market Map, By Xeno Products, Market Size (USD Million) & Growth Rate (%), 2021
  • Figure 10: Global Xenotransplantation Market Map, By Organs, Market Size (USD Million) & Growth Rate (%), 2021
  • Figure 11: Global Xenotransplantation Market Map, By End User, Market Size (USD Million) & Growth Rate (%), 2021
  • Figure 12: Global Xenotransplantation Market Map, By Region, Market Size (USD Million) & Growth Rate (%), 2021
  • Figure 13: North America Xenotransplantation Market Size, By Value (USD Million), 2021-2031F
  • Figure 14: North America Xenotransplantation Market Share, By Animal Type, By Value, 2021-2031F
  • Figure 15: North America Xenotransplantation Market Share, By Xeno Products, By Value, 2021-2031F
  • Figure 16: North America Xenotransplantation Market Share, By Organs, By Value, 2021-2031F
  • Figure 17: North America Xenotransplantation Market Share, By End User, By Value, 2021-2031F
  • Figure 18: North America Xenotransplantation Market Share, By Country, By Value, 2021-2031F
  • Figure 19: United States Xenotransplantation Market Size, By Value (USD Million), 2021-2031F
  • Figure 20: United States Xenotransplantation Market Share, By Animal Type, By Value, 2021-2031F
  • Figure 21: United States Xenotransplantation Market Share By Xeno Products, By Value, 2021-2031F
  • Figure 22: United States Xenotransplantation Market Share, By End User, By Value, 2021-2031F
  • Figure 23: Canada Xenotransplantation Market Size, By Value (USD Million), 2021-2031F
  • Figure 24: Canada Xenotransplantation Market Share, By Animal Type, By Value, 2021-2031F
  • Figure 25: Canada Xenotransplantation Market Share By Xeno Products, By Value, 2021-2031F
  • Figure 26: Canada Xenotransplantation Market Share, By End User, By Value, 2021-2031F
  • Figure 27: Mexico Xenotransplantation Market Size, By Value (USD Million), 2021-2031F
  • Figure 28: Mexico Xenotransplantation Market Share, By Animal Type, By Value, 2021-2031F
  • Figure 29: Mexico Xenotransplantation Market Share By Xeno Products, By Value, 2021-2031F
  • Figure 30: Mexico Xenotransplantation Market Share, By End User, By Value, 2021-2031F
  • Figure 31: Europe Xenotransplantation Market Size, By Value (USD Million), 2021-2031F
  • Figure 32: Europe Xenotransplantation Market Share, By Animal Type, By Value, 2021-2031F
  • Figure 33: Europe Xenotransplantation Market Share, By Xeno Products, By Value, 2021-2031F
  • Figure 34: Europe Xenotransplantation Market Share, By Organs, By Value, 2021-2031F
  • Figure 35: Europe Xenotransplantation Market Share, By End User, By Value, 2021-2031F
  • Figure 36: Europe Xenotransplantation Market Share, By Country, By Value, 2021-2031F
  • Figure 37: Germany Xenotransplantation Market Size, By Value (USD Million), 2021-2031F
  • Figure 38: Germany Xenotransplantation Market Share, By Product, By Value, 2021-2031F
  • Figure 39: Germany Xenotransplantation Market Share, By Type, By Value, 2021-2031F
  • Figure 40: Germany Xenotransplantation Market Share, By Application, By Value, 2021-2031F
  • Figure 41: Germany Xenotransplantation Market Share, By End User, By Value, 2021-2031F
  • Figure 42: France Xenotransplantation Market Size, By Value (USD Million), 2021-2031F
  • Figure 43: France Xenotransplantation Market Share, By Animal Type, By Value, 2021-2031F
  • Figure 44: France Xenotransplantation Market Share By Xeno Products, By Value, 2021-2031F
  • Figure 45: France Xenotransplantation Market Share, By End User, By Value, 2021-2031F
  • Figure 46: Spain Xenotransplantation Market Size, By Value (USD Million), 2021-2031F
  • Figure 47: Spain Xenotransplantation Market Share, By Animal Type, By Value, 2021-2031F
  • Figure 48: Spain Xenotransplantation Market Share By Xeno Products, By Value, 2021-2031F
  • Figure 49: Spain Xenotransplantation Market Share, By End User, By Value, 2021-2031F
  • Figure 50: Switzerland Xenotransplantation Market Size, By Value (USD Million), 2021-2031F
  • Figure 51: Switzerland Xenotransplantation Market Share, By Animal Type, By Value, 2021-2031F
  • Figure 52: Switzerland Xenotransplantation Market Share By Xeno Products, By Value, 2021-2031F
  • Figure 53: Switzerland Xenotransplantation Market Share, By End User, By Value, 2021-2031F
  • Figure 54: Italy Xenotransplantation Market Size, By Value (USD Million), 2021-2031F
  • Figure 55: Italy Xenotransplantation Market Share, By Animal Type, By Value, 2021-2031F
  • Figure 56: Italy Xenotransplantation Market Share By Xeno Products, By Value, 2021-2031F
  • Figure 57: Italy Xenotransplantation Market Share, By End User, By Value, 2021-2031F
  • Figure 58: Asia Pacific Xenotransplantation Market Size, By Value (USD Million), 2021-2031F
  • Figure 59: Asia Pacific Xenotransplantation Market Share, By Animal Type, By Value, 2021-2031F
  • Figure 60: Asia Pacific Xenotransplantation Market Share, By Xeno Products, By Value, 2021-2031F
  • Figure 61: Asia Pacific Xenotransplantation Market Share, By Organs, By Value, 2021-2031F
  • Figure 62: Asia Pacific Xenotransplantation Market Share, By End User, By Value, 2021-2031F
  • Figure 63: Asia Pacific Xenotransplantation Market Share, By Country, By Value, 2021-2031F
  • Figure 64: China Xenotransplantation Market Size, By Value (USD Million), 2021-2031F
  • Figure 65: China Xenotransplantation Market Share, By Animal Type, By Value, 2021-2031F
  • Figure 66: China Xenotransplantation Market Share By Xeno Products, By Value, 2021-2031F
  • Figure 67: China Xenotransplantation Market Share, By End User, By Value, 2021-2031F
  • Figure 68: Japan Xenotransplantation Market Size, By Value (USD Million), 2021-2031F
  • Figure 69: Japan Xenotransplantation Market Share, By Animal Type, By Value, 2021-2031F
  • Figure 70: Japan Xenotransplantation Market Share By Xeno Products, By Value, 2021-2031F
  • Figure 71: Japan Xenotransplantation Market Share, By End User, By Value, 2021-2031F
  • Figure 72: South Korea Xenotransplantation Market Size, By Value (USD Million), 2021-2031F
  • Figure 73: South Korea Xenotransplantation Market Share, By Animal Type, By Value, 2021-2031F
  • Figure 74: South Korea Xenotransplantation Market Share By Xeno Products, By Value, 2021-2031F
  • Figure 75: South Korea Xenotransplantation Market Share, By End User, By Value, 2021-2031F
  • Figure 76: Australia Xenotransplantation Market Size, By Value (USD Million), 2021-2031F
  • Figure 77: Australia Xenotransplantation Market Share, By Animal Type, By Value, 2021-2031F
  • Figure 78: Australia Xenotransplantation Market Share By Xeno Products, By Value, 2021-2031F
  • Figure 79: Australia Xenotransplantation Market Share, By End User, By Value, 2021-2031F
  • Figure 80: India Xenotransplantation Market Size, By Value (USD Million), 2021-2031F
  • Figure 81: India Xenotransplantation Market Share, By Animal Type, By Value, 2021-2031F
  • Figure 82: India Xenotransplantation Market Share By Xeno Products, By Value, 2021-2031F
  • Figure 83: India Xenotransplantation Market Share, By End User, By Value, 2021-2031F
  • Figure 84: South America Xenotransplantation Market Size, By Value (USD Million), 2021-2031F
  • Figure 85: South America Xenotransplantation Market Share, By Animal Type, By Value, 2021-2031F
  • Figure 86: South America Xenotransplantation Market Share, By Xeno Products, By Value, 2021-2031F
  • Figure 87: South America Xenotransplantation Market Share, By End User, By Value, 2021-2031F
  • Figure 88: South America Xenotransplantation Market Share, By Country, By Value, 2021-2031F
  • Figure 89: Brazil Xenotransplantation Market Size, By Value (USD Million), 2021-2031F
  • Figure 90: Brazil Xenotransplantation Market Share, By Animal Type, By Value, 2021-2031F
  • Figure 91: Brazil Xenotransplantation Market Share By Xeno Products, By Value, 2021-2031F
  • Figure 92: Brazil Xenotransplantation Market Share, By End User, By Value, 2021-2031F
  • Figure 93: Argentina Xenotransplantation Market Size, By Value (USD Million), 2021-2031F
  • Figure 94: Argentina Xenotransplantation Market Share, By Animal Type, By Value, 2021-2031F
  • Figure 95: Argentina Xenotransplantation Market Share By Xeno Products, By Value, 2021-2031F
  • Figure 96: Argentina Xenotransplantation Market Share, By End User, By Value, 2021-2031F
  • Figure 97: Colombia Xenotransplantation Market Size, By Value (USD Million), 2021-2031F
  • Figure 98: Colombia Xenotransplantation Market Share, By Animal Type, By Value, 2021-2031F
  • Figure 99: Colombia Xenotransplantation Market Share By Xeno Products, By Value, 2021-2031F
  • Figure 100: Colombia Xenotransplantation Market Share, By End User, By Value, 2021-2031F
  • Figure 101: Middle East & Africa Xenotransplantation Market Size, By Value (USD Million), 2021-2031F
  • Figure 102: Middle East & Africa Xenotransplantation Market Share, By Animal Type, By Value, 2021-2031F
  • Figure 103: Middle East & Africa Xenotransplantation Market Share, By Xeno Products, By Value, 2021-2031F
  • Figure 104: Middle East & Africa Xenotransplantation Market Share, By Organs, By Value, 2021-2031F
  • Figure 105: Middle East & Africa Xenotransplantation Market Share, By End User, By Value, 2021-2031F
  • Figure 106: Middle East & Africa Xenotransplantation Market Share, By Country, By Value, 2021-2031F
  • Figure 107: Egypt Xenotransplantation Market Size, By Value (USD Million), 2021-2031F
  • Figure 108: Egypt Xenotransplantation Market Share, By Animal Type, By Value, 2021-2031F
  • Figure 109: Egypt Xenotransplantation Market Share By Xeno Products, By Value, 2021-2031F
  • Figure 110: Egypt Xenotransplantation Market Share, By End User, By Value, 2021-2031F
  • Figure 111: Saudi Arabia Xenotransplantation Market Size, By Value (USD Million), 2021-2031F
  • Figure 112: Saudi Arabia Xenotransplantation Market Share, By Animal Type, By Value, 2021-2031F
  • Figure 113: Saudi Arabia Xenotransplantation Market Share By Xeno Products, By Value, 2021-2031F
  • Figure 114: Saudi Arabia Xenotransplantation Market Share, By End User, By Value, 2021-2031F
  • Figure 115: South Africa Xenotransplantation Market Size, By Value (USD Million), 2021-2031F
  • Figure 116: South Africa Xenotransplantation Market Share, By Animal Type, By Value, 2021-2031F
  • Figure 117: South Africa Xenotransplantation Market Share By Xeno Products, By Value, 2021-2031F
  • Figure 118: South Africa Xenotransplantation Market Share, By End User, By Value, 2021-2031F
  • Figure 119: UAE Xenotransplantation Market Size, By Value (USD Million), 2021-2031F
  • Figure 120: UAE Xenotransplantation Market Share, By Animal Type, By Value, 2021-2031F
  • Figure 121: UAE Xenotransplantation Market Share By Xeno Products, By Value, 2021-2031F
  • Figure 122: UAE Xenotransplantation Market Share, By End User, By Value, 2021-2031F
目次
Product Code: 10660

Global xenotransplantation market is expected to grow at a CAGR of 8.52% and reach USD 1289.11 million in 2031. This can be attributed to the rise in surgeries and improved understanding of immune system. Chronic kidney disease is a major public health issue in the United States, affecting over eight million people. When kidney function reaches a certain point, patients have end-stage renal disease and require dialysis or transplantation to live. More than 340,000 people are currently on dialysis, with 106,000 new patients added in 2019. Over 140,000 people had a functioning kidney transplant in the last 20 years, the prevalence of end-stage renal disease in these two populations has tripled. In 2020, medicare expenditures for end-stage renal disease are expected to exceed USD 28 billion.

Rise in Surgeries Increases the Demand for Xenotransplantation

Some of the factors that are likely to drive the growth of the xenotransplantation market include an increase in the volume of organ transplantation surgeries, an increase in the occurrence of chronic diseases, an increase in investment for the development of advanced and technical products, and an increase in the geriatric population. Changing lifestyles among the growing population, on the other hand, would increase numerous opportunities, which is expected to lead to a growth of xenotransplantation market throughout the forecast period.

Deceased donor kidney transplant was performed on 10,659 patients, while a live donor kidney transplant was performed on 6,432 patients. However, there are currently over 74,000 people on the national waiting list for a deceased donor kidney transplant. Even though the number of kidney transplants performed each year is increasing, the waiting list continues to grow. Every day, twelve people die while waiting for a kidney transplant.

Increasing demand for tissue and organ transplantation fuel the demand for xenotransplantation

The global demand for organ transplantation has increased rapidly over the last decade due to an increase in the incidence of vital organ failure, rising success, and greater improvement in post-transplant outcome. However, the lack of sufficient organs for transplantation to meet current demand has resulted in major organ shortage crises. As a result, the number of patients on transplant waiting lists and the number of patients dying while on the waiting list has increased significantly.

Improved understanding of immune system to drive global xenotransplantation market

Organ transplantation is one of the success stories of the second half of the twentieth century. Indeed, its success has resulted in the referral of an increasing number of patients, resulting in a scarcity of donor organs. Our better understanding of the immune system and the immune rejection process has resulted in the development of therapies that, in theory, will overcome the robust immune responses associated with xenogeneic tissue transplantation. In the coming years, human clinical trials using animal cells and organs to treat some of these diseases are expected to become a reality.

The introduction of advanced tissue products such as DeNovo NT also boost the xenotransplantation market

DeNovo NT Graft is a juvenile cartilage implant that is particulate and used to repair articular cartilage damage. Its purpose is to give surgeons an early-intervention option for articular cartilage repair. The DeNovo NT Graft is a single-stage procedure for treating articular cartilage defects in a variety of anatomical applications such as the knee, ankle, hip, shoulder, and elbow. DeNove having high technological advancement to treat the cases for transplantation.. Since, tissue transpIantation has been made very easy with the help of this technology and also provide relief to the adult patients suffering from cartilage or muscular problems, as a result, boosting the xenotransplantation market worldwide.

Market Segmentation

The global xenotransplantation market is segmented based on animal type, xeno product, organs, end users, region, and company. Based on animal type, the global xenotransplantation market can be split into pig, baboon, rabbit, and others. Based on xeno product, it can be further categorized into organs, tissues, and cells. Based on organs, the global xenotransplantation, market can be segmented into kidney, liver, heart, cornea, and others. Based on end-user, the market is segmented into transplant center, hospitals, and others. Regionally, the global xenotransplantation market can be categorized into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America dominates the overall global xenotransplantation market with United States having the biggest market. The United States xenotransplantation market is expected to grow at a CAGR of 8.97% and reach 427.39 million in 2031.

Company Profiles

Major companies in the market are Novartis AG, Accord Healthcare, Pfizer, Inc, F. Hoffmann-La Roche Ltd., Terumo Medical Corporation, Transonic, Astellas Pharma, Inc., Preservation Solutions, Inc. Bio Med Pvt. Ltd., and TransMedic, Pte. Ltd. Major players operating in the market are following strategies such as mergers and acquisitions, new therapy, among others, in order to stay competitive and have an edge over other players in the market.

Report Scope:

In this report, global xenotransplantation market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Xenotransplantation Market, By Animal Type:

Pig

Baboon

Rabbit

Others

  • Global Xenotransplantation Market, By Xeno Product:

Organs

Tissues

Cells

  • Global Xenotransplantation Market, By Organs:

Kidney

Liver

Heart

Cornea

Others

  • Global Xenotransplantation Market, By End User:

Hospitals

Transplant Centers

Others

  • Global Xenotransplantation Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • Spain
  • Switzerland
  • Italy

Asia-Pacific

  • China
  • Japan
  • South Korea
  • Australia
  • India

South America

  • Brazil
  • Argentina
  • Colombia

Middle East & Africa

  • Egypt
  • Saudi Arabia
  • South Africa
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global Xenotransplantation market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Xenotransplantation Market

5. Voice of Customer

  • 5.1. Xenotransplantation Awareness
  • 5.2. Factors Contributing Switch to Xenotransplantation
  • 5.3. Preference, By Animal Type
  • 5.4. Barriers to Adoption of Xenotransplantation

6. Clinical Trial Analysis

7. Patent Analysis

8. Successful Xenotransplantation Case Studies

9. Global Xenotransplantation Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Animal Type (Pig, Rabbit, Baboon, Others)
    • 9.2.2. By Xeno Product (Organs, Tissues, Cells)
      • 9.2.2.1. By Organs (Kidney, Liver, Heart, Cornea, Others)
    • 9.2.3. By End User (Hospitals, Transplant Centers, Others)
    • 9.2.4. By Region
  • 9.3. Product Market Map

10. North America Xenotransplantation Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Animal Type (Pig, Rabbit, Baboon, Others)
    • 10.2.2. By Xeno Product (Organs, Tissues, Cells)
      • 10.2.2.1. By Organs (Kidney, Liver, Heart, Cornea, Others)
    • 10.2.3. By End User (Hospitals, Transplant Centers, Others)
    • 10.2.4. By Country
  • 10.3. Policy & Regulatory Landscape
  • 10.4. North America: Country Analysis
    • 10.4.1. United States Xenotransplantation Market Outlook
      • 10.4.1.1. Market Size & Forecast
        • 10.4.1.1.1. By Value
      • 10.4.1.2. Market Share & Forecast
        • 10.4.1.2.1. By Animal Type
        • 10.4.1.2.2. By Xeno Product
        • 10.4.1.2.3. By End User
    • 10.4.2. Mexico Xenotransplantation Market Outlook
      • 10.4.2.1. Market Size & Forecast
        • 10.4.2.1.1. By Value
      • 10.4.2.2. Market Share & Forecast
        • 10.4.2.2.1. By Animal Type
        • 10.4.2.2.2. By Xeno Product
        • 10.4.2.2.3. By End User
    • 10.4.3. Canada Xenotransplantation Market Outlook
      • 10.4.3.1. Market Size & Forecast
        • 10.4.3.1.1. By Value
      • 10.4.3.2. Market Share & Forecast
        • 10.4.3.2.1. By Animal Type
        • 10.4.3.2.2. By Xeno Product
        • 10.4.3.2.3. By End User

11. Europe Xenotransplantation Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Animal Type (Pig, Rabbit, Baboon, Others)
    • 11.2.2. By Xeno Product (Organs, Tissues, Cells)
      • 11.2.2.1. By Organs (Kidney, Liver, Heart, Cornea, Others)
    • 11.2.3. By End User (Hospitals, Transplant Centers, Others)
    • 11.2.4. By Country
  • 11.3. Policy & Regulatory Landscape
  • 11.4. Europe: Country Analysis
    • 11.4.1. Germany Xenotransplantation Market Outlook
      • 11.4.1.1. Market Size & Forecast
        • 11.4.1.1.1. By Value
      • 11.4.1.2. Market Share & Forecast
        • 11.4.1.2.1. By Animal Type
        • 11.4.1.2.2. By Xeno Product
        • 11.4.1.2.3. By End User
    • 11.4.2. France Xenotransplantation Market Outlook
      • 11.4.2.1. Market Size & Forecast
        • 11.4.2.1.1. By Value
      • 11.4.2.2. Market Share & Forecast
        • 11.4.2.2.1. By Animal Type
        • 11.4.2.2.2. By Xeno Product
        • 11.4.2.2.3. By End User
    • 11.4.3. Spain Xenotransplantation Market Outlook
      • 11.4.3.1. Market Size & Forecast
        • 11.4.3.1.1. By Value
      • 11.4.3.2. Market Share & Forecast
        • 11.4.3.2.1. By Animal Type
        • 11.4.3.2.2. By Xeno Product
        • 11.4.3.2.3. By End User
    • 11.4.4. Switzerland Xenotransplantation Market Outlook
      • 11.4.4.1. Market Size & Forecast
        • 11.4.4.1.1. By Value
      • 11.4.4.2. Market Share & Forecast
        • 11.4.4.2.1. By Animal Type
        • 11.4.4.2.2. By Xeno Product
        • 11.4.4.2.3. By End User
    • 11.4.5. Italy Xenotransplantation Market Outlook
      • 11.4.5.1. Market Size & Forecast
        • 11.4.5.1.1. By Value
      • 11.4.5.2. Market Share & Forecast
        • 11.4.5.2.1. By Animal Type
        • 11.4.5.2.2. By Xeno Product
        • 11.4.5.2.3. By End User

12. Asia-Pacific Xenotransplantation Market Outlook

  • 12.1. Market Size & Forecast
    • 12.1.1. By Value
  • 12.2. Market Share & Forecast
    • 12.2.1. By Animal Type (Pig, Rabbit, Baboon, Others)
    • 12.2.2. By Xeno Product (Organs, Tissues, Cells)
      • 12.2.2.1. By Organs (Kidney, Liver, Heart, Cornea, Others)
    • 12.2.3. By End User (Hospitals, Transplant Centers, Others)
    • 12.2.4. By Country
  • 12.3. Policy & Regulatory Landscape
  • 12.4. Asia-Pacific: Country Analysis
    • 12.4.1. China Xenotransplantation Market Outlook
      • 12.4.1.1. Market Size & Forecast
        • 12.4.1.1.1. By Value
      • 12.4.1.2. Market Share & Forecast
        • 12.4.1.2.1. By Animal Type
        • 12.4.1.2.2. By Xeno Product
        • 12.4.1.2.3. By End User
    • 12.4.2. India Xenotransplantation Market Outlook
      • 12.4.2.1. Market Size & Forecast
        • 12.4.2.1.1. By Value
      • 12.4.2.2. Market Share & Forecast
        • 12.4.2.2.1. By Animal Type
        • 12.4.2.2.2. By Xeno Product
        • 12.4.2.2.3. By End User
    • 12.4.3. South Korea Xenotransplantation Market Outlook
      • 12.4.3.1. Market Size & Forecast
        • 12.4.3.1.1. By Value
      • 12.4.3.2. Market Share & Forecast
        • 12.4.3.2.1. By Animal Type
        • 12.4.3.2.2. By Xeno Product
        • 12.4.3.2.3. By End User
    • 12.4.4. Japan Xenotransplantation Market Outlook
      • 12.4.4.1. Market Size & Forecast
        • 12.4.4.1.1. By Value
      • 12.4.4.2. Market Share & Forecast
        • 12.4.4.2.1. By Animal Type
        • 12.4.4.2.2. By Xeno Product
        • 12.4.4.2.3. By End User
    • 12.4.5. Australia Xenotransplantation Market Outlook
      • 12.4.5.1. Market Size & Forecast
        • 12.4.5.1.1. By Value
      • 12.4.5.2. Market Share & Forecast
        • 12.4.5.2.1. By Animal Type
        • 12.4.5.2.2. By Xeno Product
        • 12.4.5.2.3. By End User

13. South America Xenotransplantation Market Outlook

  • 13.1. Market Size & Forecast
    • 13.1.1. By Value
  • 13.2. Market Share & Forecast
    • 13.2.1. By Animal Type (Pig, Rabbit, Baboon, Others)
    • 13.2.2. By Xeno Product (Organs, Tissues, Cells)
      • 13.2.2.1. By Organs (Kidney, Liver, Heart, Cornea, Others)
    • 13.2.3. By End User (Hospitals, Transplant Centers, Others)
    • 13.2.4. By Country
  • 13.3. Policy & Regulatory Landscape
  • 13.4. South America: Country Analysis
    • 13.4.1. Brazil Xenotransplantation Market Outlook
      • 13.4.1.1. Market Size & Forecast
        • 13.4.1.1.1. By Value
      • 13.4.1.2. Market Share & Forecast
        • 13.4.1.2.1. By Animal Type
        • 13.4.1.2.2. By Xeno Product
        • 13.4.1.2.3. By End User
    • 13.4.2. Argentina Xenotransplantation Market Outlook
      • 13.4.2.1. Market Size & Forecast
        • 13.4.2.1.1. By Value
      • 13.4.2.2. Market Share & Forecast
        • 13.4.2.2.1. By Animal Type
        • 13.4.2.2.2. By Xeno Product
        • 13.4.2.2.3. By End User
    • 13.4.3. Colombia Xenotransplantation Market Outlook
      • 13.4.3.1. Market Size & Forecast
        • 13.4.3.1.1. By Value
      • 13.4.3.2. Market Share & Forecast
        • 13.4.3.2.1. By Animal Type
        • 13.4.3.2.2. By Xeno Product
        • 13.4.3.2.3. By End User

14. Middle East and Africa Xenotransplantation Market Outlook

  • 14.1. Market Size & Forecast
    • 14.1.1. By Value
  • 14.2. Market Share & Forecast
    • 14.2.1. By Animal Type (Pig, Rabbit, Baboon, Others)
    • 14.2.2. By Xeno Product (Organs, Tissues, Cells)
      • 14.2.2.1. By Organs (Kidney, Liver, Heart, Cornea, Others)
    • 14.2.3. By End User (Hospitals, Transplant Centers, Others)
    • 14.2.4. By Country
  • 14.3. Policy & Regulatory Landscape
  • 14.4. MEA: Country Analysis
    • 14.4.1. Egypt Xenotransplantation Market Outlook
      • 14.4.1.1. Market Size & Forecast
        • 14.4.1.1.1. By Value
      • 14.4.1.2. Market Share & Forecast
        • 14.4.1.2.1. By Animal Type
        • 14.4.1.2.2. By Xeno Product
        • 14.4.1.2.3. By End User
    • 14.4.2. Saudi Arabia Xenotransplantation Market Outlook
      • 14.4.2.1. Market Size & Forecast
        • 14.4.2.1.1. By Value
      • 14.4.2.2. Market Share & Forecast
        • 14.4.2.2.1. By Animal Type
        • 14.4.2.2.2. By Xeno Product
        • 14.4.2.2.3. By End User
    • 14.4.3. South Africa Xenotransplantation Market Outlook
      • 14.4.3.1. Market Size & Forecast
        • 14.4.3.1.1. By Value
      • 14.4.3.2. Market Share & Forecast
        • 14.4.3.2.1. By Animal Type
        • 14.4.3.2.2. By Xeno Product
        • 14.4.3.2.3. By End User
    • 14.4.4. South Africa Xenotransplantation Market Outlook
      • 14.4.4.1. Market Size & Forecast
        • 14.4.4.1.1. By Value
      • 14.4.4.2. Market Share & Forecast
        • 14.4.4.2.1. By Animal Type
        • 14.4.4.2.2. By Xeno Product
        • 14.4.4.2.3. By End User

15. Market Dynamics

  • 15.1. Drivers
  • 15.2. Challenges

16. Market Trends & Developments

17. SWOT Analysis: Global Xenotransplantation Market

18. Competitive Landscape (Immunosuppressant Providers for the process of Xenotransplantation)

  • 18.1. Novartis AG
  • 18.2. Accord Healthcare
  • 18.3. Pfizer, Inc.
  • 18.4. F. Hoffmann-La Roche Ltd.
  • 18.5. Terumo Medical Corporation
  • 18.6. Transonic
  • 18.7. Astellas Pharma, Inc.
  • 18.8. Preservation Solutions, Inc
  • 18.9. Bio Med Pvt. Ltd.
  • 18.10. TransMedic, Pte. Ltd.

19. Strategic Recommendations